Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Wrong potency or content

Sub- or super-potent product, or a failed content-uniformity / assay test. You may receive too little or too much active ingredient - a direct dosing risk.

992 FDA drug recalls with this cause, newest first.

These recalls cover sub-potent or super-potent products, or a failed content-uniformity test - meaning some pills in the same batch held noticeably different amounts of active ingredient than others. Either way it is a direct dosing risk: too little to work, or too much and harmful. Thyroid hormones and compounded injectables are the classic examples, because their dose window is narrow.

Class II · Moderate risk

Heparin Sodium 5

Subpotent Drug: Out-of-Specification potency results at the 30-day stability timepoint.

Terminated Wrong potency / content SCA Pharmaceuticals NDC 70004-0650-46 D-1311-2020
Class II · Moderate risk

Tropical Lip Moisturizer

Superpotent Drug: The beginning portion of the batch appears to be approximately 25% superpotent for active ingredient Meradimate.

Terminated Wrong potency / content Yusef Manufacturing Laboratories, LLC D-1486-2020
Class II · Moderate risk

Koala Hand Sanitizer

Subpotent Drug: active ingredient ethanol tested below label claim and there is presence of undeclared isopropyl alcohol.

Terminated Wrong potency / content Beaming White Llc D-1359-2020
Class II · Moderate risk

Koala Hand Sanitizer

Subpotent Drug: active ingredient ethanol tested below label claim and there is presence of undeclared isopropyl alcohol.

Terminated Wrong potency / content Beaming White Llc D-1358-2020
Class II · Moderate risk

Koala Hand Sanitizer

Subpotent Drug: active ingredient ethanol tested below label claim and there is presence of undeclared isopropyl alcohol.

Terminated Wrong potency / content Beaming White Llc D-1357-2020
Class II · Moderate risk

Nystatin Cream

Subpotent Drug: Out of specification for assay at the 9-month interval for Nystatin Cream, USP.

Terminated Wrong potency / content Crown Laboratories NDC 0316-0221-15 D-1339-2020
Class II · Moderate risk

Nystatin Cream

Subpotent Drug: Out of specification for assay at the 9-month interval for Nystatin Cream, USP.

Terminated Wrong potency / content Crown Laboratories NDC 0316-0221-30 D-1338-2020
Class II · Moderate risk

EcoLips Sport Lip Balm

Superpotent Drug: The active ingredient, avobenzone, is used at 5% which is higher than the allowable 3% in the sunscreen formula per FDA sunscreen regulations.

Terminated Wrong potency / content Eco Lips Inc D-1310-2020